Pure red cell aplasia due to azathioprine therapy for Crohn;s disease

Nagesh Kamath, C. Pai, Thylbert Deltombe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Various mechanisms contribute to anemia in inflammatory bowel diseases (IBD), drug-related causes being less frequent. The hematological and other adverse events of azathioprine (AZA) therapy are well documented, but drug-associated pure red cell aplasia (PRCA) is an uncommon event. We hereby describe two cases of AZA-associated PRCA in patients with Crohn's disease. The diagnosis was supported by pathological reports, and prompt hematological recovery was seen with discontinuation of the offending drug. This report highlights the need to consider this rare entity in IBD patients in appropriate settings and for adopting adequate precautionary measures.

Original languageEnglish
Pages (from-to)86-87
Number of pages2
JournalIndian Journal of Pharmacology
Volume48
Issue number1
DOIs
Publication statusPublished - 01-01-2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this